Dabur India Limited

“Dabur is a clean, asset-light Ayurvedic FMCG business with durable leadership in Chyawanprash, Honey, Hajmola, and Real juices, a fortress balance sheet, and zero promoter pledging — but it is not a compounder. Domestic volume growth has stagnated at low-to-mid single digits, the naturals premium has been commoditized, international revenues face structural currency drag, and management has a consistent record of unmet guidance and uninspired capital allocation exemplified by the Badshah Masala acquisition. At 44x trailing earnings, the market is pricing in a growth re-acceleration that the last several years have not delivered, making probability-weighted 5-year returns sub-hurdle for Indian equities. The business deserves a place on the watchlist — not in the portfolio at this price.”